{"title":"Caspase-8 Blocks Receptor-Interacting Protein Kinase-1 Kinase-Independent Necroptosis during Embryogenesis.","authors":"Haiwei Zhang, Xiaoxia Wu, Ming Li, Xiaoming Li, Lingxia Wang, Jianling Liu, Yangjing Ou, Xuanhui Wu, Mingyan Xing, Fang Li, Xiaoming Zhao, Han Liu, Connor Jones, Jiangshan Deng, Qun Xie, Yue Zhang, Yan Luo, Yuwu Zhao, Haibing Zhang","doi":"10.4049/immunohorizons.2200021","DOIUrl":"https://doi.org/10.4049/immunohorizons.2200021","url":null,"abstract":"<p><p>Caspase-8 (Casp8) suppresses receptor-interacting protein kinase-3 (RIPK3)/mixed lineage kinase domain-like protein (MLKL)-dependent necroptosis, demonstrated by the genetic evidence that deletion of <i>Ripk3</i> or <i>Mlkl</i> prevented embryonic lethality of <i>Casp8</i>-deficient mice. However, the detailed mechanisms by which <i>Casp8</i> deficiency triggers necroptosis during embryonic development remain unclear. In this article, we show that <i>Casp8</i> deletion caused formation of the RIPK1-RIPK3 necrosome in the yolk sac, leading to vascularization defects, prevented by MLKL and RIPK3 deficiency, or RIPK3 RHIM mutant (RIPK3 V448P), but not by the RIPK1 kinase-dead mutant (RIPK1 K45A). In addition, <i>Ripk1<sup>K45A/K45A</sup>Casp8</i> <sup>-/-</sup> mice died on embryonic day 14.5, which was delayed to embryonic day 17.5 by ablation of one allele in <i>Ripk1</i> and was completely rescued by ablation of <i>Mlkl</i> Our results revealed an in vivo role of RIPK3 RHIM and RIPK1<sup>K45A</sup> scaffold-mediated necroptosis in <i>Casp8</i> deficiency embryonic development and suggested that the Casp8-deficient yolk sac might be implicated in identifying novel regulators as an in vivo necroptotic model.</p>","PeriodicalId":13448,"journal":{"name":"ImmunoHorizons","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40608531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ImmunoHorizonsPub Date : 2022-07-15DOI: 10.4049/immunohorizons.2200041
Saara Kaviany, Todd Bartkowiak, Daniel E Dulek, Yasmin W Khan, Madeline J Hayes, Samuel G Schaefer, Xiang Ye, Debolanle O Dahunsi, James A Connelly, Jonathan M Irish, Jeffrey C Rathmell
{"title":"Systems Immunology Analyses of <i>STAT1</i> Gain-of-Function Immune Phenotypes Reveal Heterogeneous Response to IL-6 and Broad Immunometabolic Roles for STAT1.","authors":"Saara Kaviany, Todd Bartkowiak, Daniel E Dulek, Yasmin W Khan, Madeline J Hayes, Samuel G Schaefer, Xiang Ye, Debolanle O Dahunsi, James A Connelly, Jonathan M Irish, Jeffrey C Rathmell","doi":"10.4049/immunohorizons.2200041","DOIUrl":"https://doi.org/10.4049/immunohorizons.2200041","url":null,"abstract":"<p><p>Patients with <i>STAT1</i> gain-of-function (GOF) pathogenic variants have enhanced or prolonged STAT1 phosphorylation following cytokine stimulation and exhibit increased yet heterogeneous susceptibility to infections, autoimmunity, and cancer. Although disease phenotypes are diverse and other genetic factors contribute, how <i>STAT1</i> GOF affects cytokine sensitivity and cell biology remains poorly defined. In this study, we analyzed the immune and immunometabolic profiles of two patients with known pathogenic heterozygous <i>STAT1</i> GOF mutation variants. A systems immunology approach of peripheral blood cells from these patients revealed major changes in multiple immune cell compartments relative to healthy adult and pediatric donors. Although many phenotypes of <i>STAT1</i> GOF donors were shared, including increased Th1 cells but decreased class-switched B cells and plasmacytoid dendritic cell populations, others were heterogeneous. Mechanistically, hypersensitivity for cytokine-induced STAT1 phosphorylation in memory T cell populations was particularly evident in response to IL-6 in one <i>STAT1</i> GOF patient. Immune cell metabolism directly influences cell function, and the <i>STAT1</i> GOF patients shared an immunometabolic phenotype of heightened glucose transporter 1 (GLUT1) and carnitine palmitoyl transferase 1A (CPT1a) expression across multiple immune cell lineages. Interestingly, the metabolic phenotypes of the pediatric <i>STAT1 GOF</i> donors more closely resembled or exceeded those of healthy adult than healthy age-similar pediatric donors, which had low expression of these metabolic markers. These results define new features of <i>STAT1</i> GOF patients, including a differential hypersensitivity for IL-6 and a shared increase in markers of metabolism in many immune cell types that suggests a role for STAT1 in metabolic regulation of immunity.</p>","PeriodicalId":13448,"journal":{"name":"ImmunoHorizons","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ac/a3/nihms-1843512.PMC9623573.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10155492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ImmunoHorizonsPub Date : 2022-07-11DOI: 10.4049/immunohorizons.2100107
Alex M Eddie, Kevin W Chen, Laurie B Schenkel, Kerren K Swinger, Jennifer R Molina, Kaiko Kunii, Ariel L Raybuck, Heike Keilhack, Katherine N Gibson-Corley, Mario Niepel, R Stokes Peebles, Mark R Boothby, Sung Hoon Cho
{"title":"Selective Pharmaceutical Inhibition of PARP14 Mitigates Allergen-Induced IgE and Mucus Overproduction in a Mouse Model of Pulmonary Allergic Response.","authors":"Alex M Eddie, Kevin W Chen, Laurie B Schenkel, Kerren K Swinger, Jennifer R Molina, Kaiko Kunii, Ariel L Raybuck, Heike Keilhack, Katherine N Gibson-Corley, Mario Niepel, R Stokes Peebles, Mark R Boothby, Sung Hoon Cho","doi":"10.4049/immunohorizons.2100107","DOIUrl":"https://doi.org/10.4049/immunohorizons.2100107","url":null,"abstract":"<p><p>The type 2 cytokines IL-4 and IL-13, which share use of an IL-4 receptor α-chain and its nuclear induction of the transcription factor STAT6, are crucial in elicitation and maintenance of allergic conditions including asthma. STAT6 binds poly(ADP-ribose) polymerase (PARP)14, an ADP-ribosyl monotransferase. Elimination of PARP14 by gene targeting led to attenuation of OVA-specific allergic lung inflammation. However, PARP14 has multiple functional domains apart from the portion that catalyzes ADP-ribosylation, and it is not clear whether inhibition of the catalytic function has any biological consequence. Using BALB/c mice sensitized to the allergen <i>Alternaria alternata,</i> we show that peroral administration of RBN012759, a highly selective inhibitor of ADP-ribosylation by PARP14 with negligible impact on other members of the PARP gene family, achieved biologically active plasma concentrations and altered several responses to the Ag. Specifically, the pharmaceutical compound decreased mucus after allergen challenge, blunted the induced increases in circulating IgE, and prevented suppression of IgG2a. We conclude that PARP14 catalytic activity can contribute to pathogenesis in allergic or atopic processes and propose that other biological endpoints dependent on ADP-ribosylation by PARP14 can be targeted using selective inhibition.</p>","PeriodicalId":13448,"journal":{"name":"ImmunoHorizons","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182383/pdf/nihms-1889426.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9451329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ImmunoHorizonsPub Date : 2022-07-05DOI: 10.4049/immunohorizons.2200025
David A Constant, Jacob A Van Winkle, Eden VanderHoek, Simone E Dekker, M Anthony Sofia, Emilie Regner, Nir Modiano, V Liana Tsikitis, Timothy J Nice
{"title":"Transcriptional and Cytotoxic Responses of Human Intestinal Organoids to IFN Types I, II, and III.","authors":"David A Constant, Jacob A Van Winkle, Eden VanderHoek, Simone E Dekker, M Anthony Sofia, Emilie Regner, Nir Modiano, V Liana Tsikitis, Timothy J Nice","doi":"10.4049/immunohorizons.2200025","DOIUrl":"10.4049/immunohorizons.2200025","url":null,"abstract":"<p><p>The three types of IFN have roles in antimicrobial immunity and inflammation that must be properly balanced to maintain tissue homeostasis. For example, IFNs are elevated in the context of inflammatory bowel disease and may synergize with inflammatory cytokines such as TNF-α to promote tissue damage. Prior studies suggest that in mouse intestinal epithelial cells (IECs), type III IFNs are preferentially produced during viral infections and are less cytotoxic than type I IFN. In this study, we generated human IEC organoid lines from biopsies of ileum, ascending colon, and sigmoid colon of three healthy subjects to establish the baseline responses of normal human IECs to types I, II, and III IFN. We found that all IFN types elicited responses that were qualitatively consistent across intestinal biopsy sites. However, IFN types differed in magnitude of STAT1 phosphorylation and identity of genes in their downstream transcriptional programs. Specifically, there was a core transcriptional module shared by IFN types, but types I and II IFN stimulated unique transcriptional modules beyond this core gene signature. The transcriptional modules of type I and II IFN included proapoptotic genes, and expression of these genes correlated with potentiation of TNF-α cytotoxicity. These data define the response profiles of healthy human IEC organoids across IFN types, and they suggest that cytotoxic effects mediated by TNF-α in inflamed tissues may be amplified by a simultaneous high-magnitude IFN response.</p>","PeriodicalId":13448,"journal":{"name":"ImmunoHorizons","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243893/pdf/nihms-1900508.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9633709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ImmunoHorizonsPub Date : 2022-06-24DOI: 10.4049/immunohorizons.2200036
Fernando Alvarez, Roman Istomine, Hilary Hendin, Breanna Hodgins, Stephane Pillet, Jörg H Fritz, Nathalie Charland, Brian J Ward, Ciriaco A Piccirillo
{"title":"A Hemagglutinin 1 Carrying Plant-Based Virus-like Particle Vaccine Generates an Efficacious Cellular Response by Exploiting IL-1 Signaling in Both Adult and Aged Mice.","authors":"Fernando Alvarez, Roman Istomine, Hilary Hendin, Breanna Hodgins, Stephane Pillet, Jörg H Fritz, Nathalie Charland, Brian J Ward, Ciriaco A Piccirillo","doi":"10.4049/immunohorizons.2200036","DOIUrl":"https://doi.org/10.4049/immunohorizons.2200036","url":null,"abstract":"<p><p>Inactivated influenza vaccines have struggled to provide consistent protection in older individuals. Circumventing immune senescence, an aging of the immune response characterized by weak humoral responses to vaccines, and unchecked inflammation during infection require novel immunization strategies. Plant-based virus-like particles (VLPs) bearing recombinant hemagglutinin proteins have been shown to provide protection in older animals in preclinical challenge studies, despite eliciting relatively low or absent humoral responses. The nature of the cellular response induced by these vaccines and its evolution during infection have not yet been fully characterized, however. Using a murine model that recapitulates features of human immune senescence, we assessed T cell responses to vaccination with a VLP bearing the hemagglutinin of H1N1/California 07/2009 (H1-VLP) before and after challenge in young and aged BALB/c mice (2 and 18 mo old, respectively). We report that two i.m. doses of H1-VLP (3 μg) vaccine 21 d apart generated H1-specific Th1 and Th2 cells associated with the prevention of prolonged pulmonary inflammation and mortality in both adult and aged mice. While investigating the regulation of cellular immunity, we identified a unique IL-1R1<sup>+</sup> tissue-adapted regulatory T cell population in the lungs of both H1-VLP-vaccinated adult and aged mice, suggesting a novel regulatory T cell population associated with vaccine-mediated protection. Collectively, this study provides preclinical evidence that the plant-based H1-VLP vaccine may act, in part, by preventing exacerbated immune responses against influenza A.</p>","PeriodicalId":13448,"journal":{"name":"ImmunoHorizons","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40396844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ImmunoHorizonsPub Date : 2022-06-24DOI: 10.4049/immunohorizons.2200029
Alka Khaitan, Dibyadyuti Datta, Caitlin Bond, Michael Goings, Katrina Co, Eliud O Odhiambo, Lucy Miller, Lin Zhang, Stephanie Beasley, Josh Poorbaugh, Chandy C John
{"title":"Level and Duration of IgG and Neutralizing Antibodies to SARS-CoV-2 in Children with Symptomatic or Asymptomatic SARS-CoV-2 Infection.","authors":"Alka Khaitan, Dibyadyuti Datta, Caitlin Bond, Michael Goings, Katrina Co, Eliud O Odhiambo, Lucy Miller, Lin Zhang, Stephanie Beasley, Josh Poorbaugh, Chandy C John","doi":"10.4049/immunohorizons.2200029","DOIUrl":"https://doi.org/10.4049/immunohorizons.2200029","url":null,"abstract":"<p><p>There are conflicting data about level and duration of Abs to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children after symptomatic or asymptomatic infection. In this human population, we enrolled adults and children in a prospective 6-mo study in the following categories: 1) symptomatic, SARS-CoV-2 PCR<sup>+</sup> (SP<sup>+</sup>; children, <i>n</i> = 8; adults, <i>n</i> = 16), 2) symptomatic, PCR<sup>-</sup>, or untested (children, <i>n</i> = 27), 3) asymptomatic exposed (children, <i>n</i> = 13), and 4) asymptomatic, no known exposure (children, <i>n</i> = 19). Neutralizing Abs (nAbs) and IgG Abs to SARS-CoV-2 Ags and spike protein variants were measured by multiplex serological assay. All SP<sup>+</sup> children developed nAb, whereas 81% of SP<sup>+</sup> adults developed nAb. Decline in the presence of nAb over 6 mo was not significant in symptomatic children (100 to 87.5%; <i>p</i> = 0.32) in contrast to adults (81.3 to 50.0%; <i>p</i> = 0.03). Among children with nAb (<i>n</i> = 22), nAb titers and change in titers over 6 mo were similar in symptomatic and asymptomatic children. In children and adults, nAb levels postinfection were 10-fold lower than those reported after SARS-CoV-2 mRNA vaccination. Levels of IgG Abs in children to SARS-CoV-2 Ags and spike protein variants were similar to those in adults. IgG levels to primary Ags decreased over time in children and adults, but levels to three spike variants decreased only in children. Children with asymptomatic or symptomatic SARS-CoV-2 infection develop nAbs that remain present longer than in adults but wane in titer over time and broad IgG Abs that also wane in level over time. However, nAb levels were lower postinfection than those reported after immunization.</p>","PeriodicalId":13448,"journal":{"name":"ImmunoHorizons","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40396843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ImmunoHorizonsPub Date : 2022-06-24DOI: 10.4049/immunohorizons.2200044
Maria A Oliver, Rhys T Meredith, Bryan R Smith, Max D Bermingham, Nicole F Brackett, Martin D Chapman
{"title":"Longitudinal T Cell Responses against Ancestral, Delta, and Omicron SARS-CoV-2 Variants Determined by Rapid Cytokine Release Assay in Whole Blood.","authors":"Maria A Oliver, Rhys T Meredith, Bryan R Smith, Max D Bermingham, Nicole F Brackett, Martin D Chapman","doi":"10.4049/immunohorizons.2200044","DOIUrl":"https://doi.org/10.4049/immunohorizons.2200044","url":null,"abstract":"<p><p>T cell immunity to natural SARS-CoV-2 infection may be more robust and longer lived than Ab responses. Accurate assessment of T cell responses is critical for understanding the magnitude and longevity of immunity across patient cohorts, and against emerging variants. By establishing a simple, accurate, and rapid whole blood test, natural and vaccine-induced SARS-CoV-2 immunity was determined. Cytokine release in whole blood stimulated with peptides specific for SARS-CoV-2 was measured in donors with previous PCR-confirmed infection, suspected infection, or with no exposure history (<i>n</i> = 128), as well as in donors before and after vaccination (<i>n</i> = 32). Longitudinal assessment of T cell responses following initial vaccination and booster vaccination was also conducted (<i>n</i> = 50 and <i>n</i> = 62, respectively). Cytokines were measured by ELISA and multiplex array. IL-2 and IFN-γ were highly elevated in PCR-confirmed donors compared with history-negative controls, with median levels ∼33-fold and ∼48-fold higher, respectively. Receiver operating curves showed IL-2 as the superior biomarker (area under the curve = 0.9950). Following vaccination, all donors demonstrated a positive IL-2 response. Median IL-2 levels increased ∼32-fold from prevaccination to postvaccination in uninfected individuals. Longitudinal assessment revealed that T cell responses were stable up to 6 mo postvaccination. No significant differences in cytokine production were observed between stimulations with Wuhan, Delta, or Omicron peptides. This rapid, whole blood-based test can be used to make comparable longitudinal assessments of vaccine-induced T cell immunity across multiple cohorts and against variants of concern, thus aiding decisions on public health policies.</p>","PeriodicalId":13448,"journal":{"name":"ImmunoHorizons","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40396845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ImmunoHorizonsPub Date : 2022-06-23DOI: 10.4049/immunohorizons.2200045
Gaurav Shrivastava, Paola Carolina Valenzuela-Leon, Andrezza Campos Chagas, Olivia Kern, Karina Botello, Yixiang Zhang, Ines Martin-Martin, Markus Berger Oliveira, Lucas Tirloni, Eric Calvo
{"title":"Alboserpin, the Main Salivary Anticoagulant from the Disease Vector <i>Aedes albopictus</i>, Displays Anti-FXa-PAR Signaling In Vitro and In Vivo.","authors":"Gaurav Shrivastava, Paola Carolina Valenzuela-Leon, Andrezza Campos Chagas, Olivia Kern, Karina Botello, Yixiang Zhang, Ines Martin-Martin, Markus Berger Oliveira, Lucas Tirloni, Eric Calvo","doi":"10.4049/immunohorizons.2200045","DOIUrl":"10.4049/immunohorizons.2200045","url":null,"abstract":"<p><p>Blood-feeding arthropods secrete potent salivary molecules, which include platelet aggregation inhibitors, vasodilators, and anticoagulants. Among these molecules, Alboserpin, the major salivary anticoagulant from the mosquito vector <i>Aedes albopictus</i>, is a specific inhibitor of the human coagulation factor Xa (FXa). In this study, we investigated the anti-inflammatory properties of Alboserpin, in vitro and in vivo. In vitro, Alboserpin inhibited FXa-induced protease-activated receptor (PAR)-1, PAR-2, PAR-3, VCAM, ICAM, and NF-κB gene expression in primary dermal microvascular endothelial cells. Alboserpin also prevented FXa-stimulated ERK1/2 gene expression and subsequent inflammatory cytokine release (MCP-1, TNF-α, IL-6, IL-8, IL-1β, IL-18). In vivo, Alboserpin reduced paw edema induced by FXa and subsequent release of inflammatory cytokines (CCL2, MCP-1, IL-1α, IL-6, IL-1β). Alboserpin also reduced FXa-induced endothelial permeability in vitro and in vivo. These findings show that Alboserpin is a potent anti-inflammatory molecule, in vivo and in vitro, and may play a significant role in blood feeding.</p>","PeriodicalId":13448,"journal":{"name":"ImmunoHorizons","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10753553/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40333372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ImmunoHorizonsPub Date : 2022-06-22DOI: 10.4049/immunohorizons.2200019
Jordan Philpott, Simon Kazimierczyk, Parimal Korgaonkar, Evan Bordt, Jaclyn Zois, Chithirachelvi Vasudevan, Di Meng, Ishan Bhatia, Naifang Lu, Brittany Jimena, Caryn Porter, Bobby J Cherayil, Nitya Jain
{"title":"RXRα Regulates the Development of Resident Tissue Macrophages.","authors":"Jordan Philpott, Simon Kazimierczyk, Parimal Korgaonkar, Evan Bordt, Jaclyn Zois, Chithirachelvi Vasudevan, Di Meng, Ishan Bhatia, Naifang Lu, Brittany Jimena, Caryn Porter, Bobby J Cherayil, Nitya Jain","doi":"10.4049/immunohorizons.2200019","DOIUrl":"https://doi.org/10.4049/immunohorizons.2200019","url":null,"abstract":"<p><p>Resident tissue macrophages (RTMs) develop from distinct waves of embryonic progenitor cells that seed tissues before birth. Tissue-specific signals drive a differentiation program that leads to the functional specialization of RTM subsets. Genetic programs that regulate the development of RTMs are incompletely understood, as are the mechanisms that enable their maintenance in adulthood. In this study, we show that the ligand-activated nuclear hormone receptor, retinoid X receptor (RXR)α, is a key regulator of murine RTM development. Deletion of RXRα in hematopoietic precursors severely curtailed RTM populations in adult tissues, including the spleen, peritoneal cavity, lung, and liver. The deficiency could be traced to the embryonic period, and mice lacking RXRα in hematopoietic lineages had greatly reduced numbers of yolk sac and fetal liver macrophages, a paucity that persisted into the immediate postnatal period.</p>","PeriodicalId":13448,"journal":{"name":"ImmunoHorizons","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c2/9b/nihms-1824118.PMC9316889.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40194652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}